Deep Health Ai India Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Deep Health AI India Ltd is ₹ 2.38 as of 05 May 15:30 . The P/E Ratio of Deep Health AI India Ltd changed from 65.7 on March 2024 to 0 on March 2022 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Novelix Pharmaceuticals Ltd changed from 0 on March 2024 to 0 on March 2022 . This represents a CAGR of 0.0% over 4 years The Market Cap of Deep Health AI India Ltd changed from ₹ 18.91 crore on March 2024 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of Novelix Pharmaceuticals Ltd changed from ₹ 5.48 crore on March 2021 to ₹ 7.2 crore on March 2022 . This represents a CAGR of 14.62% over 2 years The revenue of Deep Health AI India Ltd for the Dec '25 is ₹ 4.21 crore as compare to the Sep '25 revenue of ₹ 3.51 crore. This represent the growth of 19.94% The revenue of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Deep Health AI India Ltd for the Dec '25 is ₹ 3.67 crore as compare to the Sep '25 ebitda of ₹ 3.39 crore. This represent the growth of 8.26% The ebitda of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Deep Health AI India Ltd changed from ₹ 0.29 crore to ₹ 3.04 crore over 7 quarters. This represents a CAGR of 282.94% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Deep Health AI India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Deep Health AI India Ltd

Deep Diamond India Limited was established in 1994, with the object to engaged in the manufacture and wholesale of gold set jewellery with diamonds.
The company also deals in loose diamonds, solitaires, and gold frames.
It offers Pendants, Nose pins, Rings, Bangles, Earrings, Pendant sets, Necklace sets, Bracelets, and others. From financial year 2022-23, the Company has also started business of providing consultancy service to Pharmaceutical Industry. During year 2023, Company diversified its business into pharmaceuticals business with professional management team at its Board.
Located in Mumbai, Deep Diamond India is a pharmaceutical company that focuses on developing and marketing innovative drugs and therapies to address unmet medical needs.
Their product portfolio includes prescription drugs, over-the-counter medicines, and medical devices.

About Novelix Pharmaceuticals Ltd

Novelix Pharmaceuticals Limited was initially incorporated as 'Trimurthi Securities Limited' on December 13, 1994.
The name of the Company was changed from Trimurthi Securities Limited to Trimurthi Drugs & Pharmaceuticals Limited.
Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Limited and again to Trimurthi Limited in May, 2016.
The Company has altered the name to Novelix Pharmaceuticals Limited in 2025. Initially, the company was engaged in finance and investments in securities.
They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.

FAQs for the comparison of Deep Health AI India Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Deep Diamond India Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Deep Diamond India Ltd is 34 Cr while Market cap of Novelix Pharmaceuticals Ltd is 58 Cr

What are the key factors driving the stock performance of Deep Diamond India Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Deep Diamond India Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Deep Diamond India Ltd and Novelix Pharmaceuticals Ltd?

As of May 5, 2026, the Deep Diamond India Ltd stock price is INR ₹2.38. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹40.5.

How do dividend payouts of Deep Diamond India Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Deep Diamond India Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.